TrialScope Revenue and Competitors
Estimated Revenue & Valuation
- TrialScope's estimated annual revenue is currently $1.5M per year.
- TrialScope's estimated revenue per employee is $87,000
Employee Data
- TrialScope has 17 Employees.
- TrialScope grew their employee count by -29% last year.
TrialScope's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO | Reveal Email/Phone |
2 | Director Business Development | Reveal Email/Phone |
3 | Director Product Management | Reveal Email/Phone |
4 | Chief Financial Officer | Reveal Email/Phone |
5 | Senior Project Manager | Reveal Email/Phone |
TrialScope Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $22.6M | 142 | -18% | N/A | N/A |
#2 | $41.3M | 259 | 44% | N/A | N/A |
#3 | $808.8M | 3984 | 9% | N/A | N/A |
#4 | $1320M | 1901 | 8% | $445M | N/A |
#5 | $513.8M | 2478 | 11% | $215M | N/A |
#6 | $16.7M | 115 | 4% | N/A | N/A |
#7 | $469.4M | 2264 | 8% | $298.8M | N/A |
#8 | $84.3M | 465 | 33% | N/A | N/A |
#9 | $19.4M | 127 | -2% | $46.6M | N/A |
#10 | $81.2M | 448 | 25% | N/A | N/A |
What Is TrialScope?
TrialScope Disclose is now part of Pharma Intelligence. TrialScope Disclose makes centralizing, structuring and activating clinical trial information simple, for use across the organization and at every stage of the study. Our integrated platform is used by 16 of the top 20 clinical trial sponsors in the world, who rely on TrialScope Disclose to ensure disclosure compliance, maximize trial transparency, improve patient engagement and accelerate study recruitment. To learn more, visit TrialScope.com.
keywords:N/AN/A
Total Funding
17
Number of Employees
$1.5M
Revenue (est)
-29%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $1.5M | 17 | -62% | N/A |
#2 | $1.5M | 17 | -11% | N/A |
#3 | $2.1M | 17 | -26% | N/A |
#4 | $4.9M | 17 | -19% | $19.4M |
#5 | $7.5M | 17 | -19% | $56.6M |